Gene targeting techniques for Huntington's disease

被引:18
|
作者
Fields, Eric [1 ]
Vaughan, Erik [1 ]
Tripu, Deepika [1 ]
Lim, Isabelle [1 ]
Shrout, Katherine [1 ]
Conway, Jessica [1 ]
Salib, Nicole [1 ]
Lee, Yubin [1 ]
Dhamsania, Akash [1 ]
Jacobsen, Michael [1 ]
Woo, Ashley [1 ]
Xue, Huijing [2 ]
Cao, Kan [1 ,2 ]
机构
[1] Univ Maryland, Gemstone Honors Program, College Pk, MD 20742 USA
[2] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA
关键词
Huntington's disease; Allele-specific targeting; Prime editing; SNPs; MUTANT HUNTINGTIN; CAG REPEAT; GUT MICROBIOTA; MOUSE MODEL; RNA; MECHANISMS; THERAPY; PHOSPHORYLATION; INACTIVATION; CILIOGENESIS;
D O I
10.1016/j.arr.2021.101385
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Huntington's disease (HD) is an autosomal neurodegenerative disorder caused by extended trinucleotide CAG repetition in the HTT gene. Wild-type huntingtin protein (HTT) is essential, involved in a variety of crucial cellular functions such as vesicle transportation, cell division, transcription regulation, autophagy, and tissue maintenance. The mutant HTT (mHTT) proteins in the body interfere with HTT's normal cellular functions and cause additional detrimental effects. In this review, we discuss multiple approaches targeting DNA and RNA to reduce mHTT expression. These approaches are categorized into non-allele-specific silencing and allele-specificsilencing using Single Nucleotide Polymorphisms (SNPs) and haplogroup analysis. Additionally, this review discusses a potential application of recent CRISPR prime editing technology in targeting HD.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Accumulating gene errors drive Huntington's disease
    Rajagopal, Veera M.
    Gelfman, Sahar
    NATURE, 2025, 639 (8055) : 584 - 586
  • [42] Gene Expression Profiling of Depression in Huntington's Disease
    Colpo, Gabriela D.
    Rocha, Natalia P.
    Stimming, Erin Furr
    Teixeira, Antonio L.
    NEUROTHERAPEUTICS, 2019, 16 (04) : 1355 - 1355
  • [43] Moving toward a gene therapy for Huntington’s disease
    J C Glorioso
    J B Cohen
    D L Carlisle
    I Munoz-Sanjuan
    R M Friedlander
    Gene Therapy, 2015, 22 : 931 - 933
  • [44] Prospectives for cell and gene therapy in Huntington's disease
    Bachoud-Levi, AC
    Hantraye, P
    Peschanski, M
    NEURONAL DEGENERATION AND REGENERATION: FROM BASIC MECHANISMS TO PROSPECTS FOR THERAPY, 1998, 117 : 511 - 524
  • [45] An update on Huntington's disease: from the gene to the clinic
    Kim, Samuel D.
    Fung, Victor S. C.
    CURRENT OPINION IN NEUROLOGY, 2014, 27 (04) : 477 - 483
  • [46] Revisiting cell and gene therapies in Huntington's disease
    Beatriz, Margarida
    Lopes, Carla
    Ribeiro, Ana Claudia S.
    Rego, Ana Cristina Carvalho
    JOURNAL OF NEUROSCIENCE RESEARCH, 2021, 99 (07) : 1744 - 1762
  • [47] Chromosomal profiles of gene expression in Huntington's disease
    Anderson, Alexander N.
    Roncaroli, Federico
    Hodges, Angela
    Deprez, Manuel
    Turkheimer, Federico E.
    BRAIN, 2008, 131 : 381 - 388
  • [48] Gene Expression Profiling of depression in Huntington's disease
    Colpo, G.
    Rocha, N.
    Stimming, E. Furr
    Lucio, A.
    MOVEMENT DISORDERS, 2019, 34 : S4 - S4
  • [49] Moving toward a gene therapy for Huntington's disease
    Glorioso, J. C.
    Cohen, J. B.
    Carlisle, D. L.
    Munoz-Sanjuan, I.
    Friedlander, R. M.
    GENE THERAPY, 2015, 22 (12) : 931 - 933
  • [50] Gene silencing approaches for the treatment of Huntington's disease
    Merienne, Nicolas
    Deglon, Nicole
    M S-MEDECINE SCIENCES, 2015, 31 (02): : 159 - 167